WESTPHAL CHRISTOPH H enters TSCAN THERAPEUTICS, INC. with 1.04M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 7/15/2021ACC: 0000899243-21-028519
Director10% Owner
Since Jul 2021
1.04M
Baseline shares
88% direct
914.63K
Direct ownership
1 position
1.15M
Derivative underlying
3 instruments
2
Security positions
121.95K indirect
Non-Derivative Holdings2
Voting Common Stock
DirectShares owned914.63K
Voting Common Stock
IndirectShares owned121.95K
Total
914.63K direct·121.95K indirect1.04M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Voting Common Stock | 914.63K | Direct |
| Voting Common Stock | 121.95K | Indirect |
| Total | 1.04M | 914.63K direct·121.95K indirect |
Derivative Holdings3
Series A Preferred Stock
IndirectUnderlying security
Voting Common Stock
Underlying shares
641.85K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series C Preferred Stock
IndirectUnderlying security
Voting Common Stock
Underlying shares
171.06K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series B Preferred Stock
IndirectUnderlying security
Voting Common Stock
Underlying shares
332.59K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
1.15M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Voting Common Stock | — | — | 641.85K | N/A | |
| Series C Preferred Stock Indirect | Voting Common Stock | — | — | 171.06K | N/A | |
| Series B Preferred Stock Indirect | Voting Common Stock | — | — | 332.59K | N/A | |
| Total | 1.15M | 0.00 | ||||